News Medical

How an AI system learned to write expert-level scientific code

A new study shows how ERA combines large language models with tree search to rapidly build expert-level research software, outperforming leading benchmarks in tasks from single-cell genomics to ...
JD Supra

Rethinking the Pantry: FDA Finalizes Post‑Market Plan for Food Chemicals and Initiates Reassessments of BHT and ADA

On May 12, 2026, the U.S. Food and Drug Administration (FDA) announced a major milestone in its approach to post-market oversight of chemicals in the food supply, finalizing a new proactive food ...
The American Journal of Managed Care

5 Key Regulatory Shifts From Makary's Era at the FDA

Single adequate and well-controlled trial plus confirmatory evidence became the default approval paradigm, formalizing a trend already common for first-in-class oncology and rare-disease products.
Newsweek

FDA Commissioner Marty Makary Resigns: Who is Acting Chief Kyle Diamantas?

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary ...
TribLIVE.com

Cash, code words and contraband: Guards charged in Fayette prison drug ring

State corrections officials have fired two jail guards they say ran a drug ring at a Fayette County prison, fueled by code words shared over jail phone calls and packages mailed from nonexistent ...
MarketWatch

Boston Scientific to Update Pacemakers in Recall, FDA Says

The Food and Drug Administration said Boston Scientific will upgrade certain pacemakers to a new software as part of a recall. Boston Scientific issued a letter to affected customers recommending all ...
Reuters

US FDA issues recall of Boston Scientific heart devices

May 7 (Reuters) - Boston Scientific (BSX.N), opens new tab has issued an urgent recall to correct several heart devices after the U.S. Food and Drug Administration classified the action as its ‌most ...
Scientific American

Why the FDA rejected a ‘breakthrough’ melanoma drug

For patients whose skin cancer doesn’t respond to traditional treatments, a new drug called RP1 has been a lifeline—at least for those who can get into a clinical trial. The drug has shown so much ...
FierceBiotech

Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset

Kyverna Therapeutics has unveiled the full results from its registrational trial of miv-cel in stiff person syndrome (SPS), providing a comprehensive look at what could become the first-ever CAR-T ...
Wall Street Journal

White House Pushes for Flavored Vapes Blocked By FDA Head

The White House is pushing to allow more vape flavors on the market for the first time in years, but Food and Drug Administration Commissioner Marty Makary opposes the move and is blocking the plan, ...
Insider Monkey

Boston Scientific (BSX) Receives FDA Clearance for Asurys Fluid Management System

Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best Growth Stocks to Buy for the Next Decade. Boston Scientific Corporation (NYSE:BSX) is one of the best growth stocks to buy for the next ...